Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3563411

In Collections

This item can be found in the following collections:

Rademaker, E.; Bastiaannet, E.; Oosting, J.; Dekker-Ensink, N.G.; Kuppen, P.J.K.; Miranda, N.F.C.C. de; Liefers, G.J. (2022)

Revising the role of integrin subunit beta 4 expression in colon cancer progression and survival

Article / Letter to editor
Purpose Integrin subunit beta 4 (beta 4) has been proposed to play an important role in colon cancer progression through its involvement in hemidesmosome disassembly processes and tumor cell migration. However, the association between beta 4 expression and clinicopathological outcomes in colon cancer remains unclear.Methods Expression of beta 4 was assessed by immunohistochemistry in a large cohort of 651 colon cancer patients, the largest colon cancer cohort so far. Chi-squared tests were used to study the association between beta 4 expression and clinicopathological features. Overall and disease-free survival were assessed by Cox proportional hazard models.Results Loss of beta 4 expression was associated with local tumor invasion. Only 17.9% of the pT1 tumors displayed weak beta 4 expression level versus 28.1% of pT4 tumors, and 25.0% of the pT1 tumors had a high expression level versus 8.6% of the pT4 tumors (p = 0.012). No association between beta 4 expression and overall (p = 0...Show morePurpose Integrin subunit beta 4 (beta 4) has been proposed to play an important role in colon cancer progression through its involvement in hemidesmosome disassembly processes and tumor cell migration. However, the association between beta 4 expression and clinicopathological outcomes in colon cancer remains unclear.Methods Expression of beta 4 was assessed by immunohistochemistry in a large cohort of 651 colon cancer patients, the largest colon cancer cohort so far. Chi-squared tests were used to study the association between beta 4 expression and clinicopathological features. Overall and disease-free survival were assessed by Cox proportional hazard models.Results Loss of beta 4 expression was associated with local tumor invasion. Only 17.9% of the pT1 tumors displayed weak beta 4 expression level versus 28.1% of pT4 tumors, and 25.0% of the pT1 tumors had a high expression level versus 8.6% of the pT4 tumors (p = 0.012). No association between beta 4 expression and overall (p = 0.845) or disease-free survival (p = 0.767) was encountered, which disputes the role of beta 4 as a biomarker of malignant behavior in colon cancer.Conclusion Contradictory reports have suggested opposite roles for beta 4 expression in (colon) cancer progression. In the present large cohort of colon cancer patients, we found that beta 4 expression was not associated with worse clinical prognosis, but decreased with advanced pathological tumor stage. Future studies should establish whether loss of beta 4 expression promotes invasive characteristics of colon cancer cells.Show less
Integrin beta 4
beta 4 subunit
Biomarker
Colon cancer
Invasion
Hemidesmosome
All authors
Rademaker, E.; Bastiaannet, E.; Oosting, J.; Dekker-Ensink, N.G.; Kuppen, P.J.K.; Miranda, N.F.C.C. de; Liefers, G.J.
Date
2022-02-03
Journal
Journal of Gastrointestinal Cancer
DOI
doi:10.1007/s12029-021-00787-8
Link
https://link.springer.com/article/10.1007/s12029-021-00787-8